S-0192.2  _______________________________________________

 

                         SENATE BILL 5305

          _______________________________________________

 

State of Washington      55th Legislature     1997 Regular Session

 

By Senators Fairley, Wojahn, Goings, McAuliffe, Patterson and Kohl

 

Read first time 01/22/97.  Referred to Committee on Health & Long‑Term Care.

 

Controlling drugs used to facilitate rape.



    AN ACT Relating to controlling drugs used to facilitate rape; amending RCW 69.50.206 and 69.50.210; and prescribing penalties.

 

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:

 

    Sec. 1.  RCW 69.50.206 and 1993 c 187 s 6 are each amended to read as follows:

    (a) The drugs and other substances listed in this section, by whatever official name, common or usual name, chemical name, or brand name designated, are included in Schedule II.

    (b) Substances. (Vegetable origin or chemical synthesis.) Unless specifically excepted, any of the following substances, except those listed in other schedules, whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis:

    (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone, and their respective salts, but including the following:

    (i) Raw opium;

    (ii) Opium extracts;

    (iii) Opium fluid;

    (iv) Powdered opium;

    (v) Granulated opium;

    (vi) Tincture of opium;

    (vii) Codeine;

    (viii) Ethylmorphine;

    (ix) Etorphine hydrochloride;

    (x) Hydrocodone;

    (xi) Hydromorphone;

    (xii) Metopon;

    (xiii) Morphine;

    (xiv) Oxycodone;

    (xv) Oxymorphone; and

    (xvi) Thebaine.

    (2) Any salt, compound, isomer, derivative, or preparation thereof that is chemically equivalent or identical with any of the substances referred to in subsection (b)(1) of this section, but not including the isoquinoline alkaloids of opium.

    (3) Opium poppy and poppy straw.

    (4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves including cocaine and ecgonine, and their salts, isomers, derivatives, and salts of isomers and derivatives, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions of coca leaves which do not contain cocaine or ecgonine.

    (5) Methylbenzoylecgonine (cocaine C its salts, optical isomers, and salts of optical isomers).

    (6) Concentrate of poppy straw (The crude extract of poppy straw in either liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.)

    (c) Opiates.  Unless specifically excepted or unless in another schedule, any of the following synthetic opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation, dextrorphan and levopropoxyphene excepted:

    (1) Alfentanil;

    (2) Alphaprodine;

    (3) Anileridine;

    (4) Bezitramide;

    (5) Bulk dextropropoxyphene (nondosage forms);

    (6) Carfentanil;

    (7) Dihydrocodeine;

    (8) Diphenoxylate;

    (9) Fentanyl;

    (10) Isomethadone;

    (11) Levomethorphan;

    (12) Levorphanol;

    (13) Metazocine;

    (14) Methadone;

    (15) MethadoneCIntermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;

    (16) MoramideCIntermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid;

    (17) Pethidine (meperidine);

    (18) PethidineCIntermediate‑A, 4-cyano-1-methyl-4-phenylpiperidine;

    (19) PethidineCIntermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;

    (20) PethidineCIntermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;

    (21) Phenazocine;

    (22) Piminodine;

    (23) Racemethorphan;

    (24) Racemorphan;

    (25) Sufentanil.

    (d) Stimulants.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:

    (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers;

    (2) Methamphetamine, its salts, isomers, and salts of its isomers;

    (3) Phenmetrazine and its salts;

    (4) Methylphenidate.

    (e) Depressants.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

    (1) Amobarbital;

    (2) Flunitrazepam;

    (3) Glutethimide;

    (((3))) (4) Pentobarbital;

    (((4))) (5) Phencyclidine;

    (((5))) (6) Secobarbital.

    (f) Hallucinogenic substances.

    (1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product.  (Some other names for dronabinol [6aR-trans]-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-i-ol, or (-)-delta-9-(trans)-tetrahydrocannabinol.)

    (2) Nabilone:  Some trade or other names are ( " )-trans3-(1,1-dimethlheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzol[b,d]pyran-9-one.

    (g) Immediate precursors.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

    (1) Immediate precursor to amphetamine and methamphetamine:

    (i) Phenylacetone:  Some trade or other names phenyl-2-propanone, P2P, benzyl methyl ketone, methyl benzyl ketone.

    (2) Immediate precursors to phencyclidine (PCP):

    (i) 1-phenylcyclohexylamine;

    (ii) 1-piperidinocyclohexanecarbonitrile (PCC).

    The controlled substances in this section may be rescheduled or deleted as provided for in RCW 69.50.201.

 

    Sec. 2.  RCW 69.50.210 and 1993 c 187 s 10 are each amended to read as follows:

    Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in Schedule IV:

    (a) Any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

    (1) Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.

    (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane).

    (b) Depressants.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances having a depressant effect on the central nervous system, including their salts, isomers, and salts of isomers whenever the existence of those salts, isomers, and salts of isomers is possible within the specific chemical designation:

    (1) Alprazolam;

    (2) Barbital;

    (3) Bromazepam;

    (4) Camazepam;

    (5) Chloral betaine;

    (6) Chloral hydrate;

    (7) Chlordiazepoxide;

    (8) Clobazam;

    (9) Clonazepam;

    (10) Clorazepate;

    (11) Clotiazepam;

    (12) Cloxazolam;

    (13) Delorazepam;

    (14) Diazepam;

    (15) Estazolam;

    (16) Ethchlorvynol;

    (17) Ethinamate;

    (18) Ethyl loflazepate;

    (19) Fludiazepam;

    (20) ((Flunitrazepam;

    (21))) Flurazepam;

    (((22))) (21) Halazepam;

    (((23))) (22) Haloxazolam;

    (((24))) (23) Ketazolam;

    (((25))) (24) Loprazolam;

    (((26))) (25) Lorazepam;

    (((27))) (26) Lormetazepam;

    (((28))) (27) Mebutamate;

    (((29))) (28) Medazepam;

    (((30))) (29) Meprobamate;

    (((31))) (30) Methohexital;

    (((32))) (31) Methylphenobarbital (mephobarbital);

    (((33))) (32) Midazolam;

    (((34))) (33) Nimetazepam;

    (((35))) (34) Nitrazepam;

    (((36))) (35) Nordiazepam;

    (((37))) (36) Oxazepam;

    (((38))) (37) Oxazolam;

    (((39))) (38) Paraldehyde;

    (((40))) (39) Petrichloral;

    (((41))) (40) Phenobarbital;

    (((42))) (41) Pinazepam;

    (((43))) (42) Prazepam;

    (((44))) (43) Quazepam;

    (((45))) (44) Temazepam;

    (((46))) (45) Tetrazepam;

    (((47))) (46) Triazolam.

    (c) Any material, compound, mixture, or preparation containing any quantity of the following substance, including its salts, isomers, and salts of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:  Fenfluramine.

    (d) Stimulants.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, isomers, and salts of isomers:

    (1) Cathine((+)norpseudoephedrine);

    (2) Diethylpropion;

    (3) Fencamfamin;

    (4) Fenproporex;

    (5) Mazindol;

    (6) Mefenorex;

    (7) Pemoline (including organometallic complexes and chelates thereof);

    (8) Phentermine;

    (9) Pipradrol;

    (10) SPA ((-)-1-dimethylamino-1, 2-dephenylethane).

    (e) Other substances.  Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substance, including its salts:

    (1) Pentazocine.

    The state board of pharmacy may except by rule any compound, mixture, or preparation containing any depressant substance listed in subsection (b) of this section from the application of all or any part of this chapter if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances having a depressant effect on the central nervous system.

    The controlled substances listed in this section may be rescheduled or deleted as provided for in RCW 69.50.201.

 


                            --- END ---